By InvitationNot Applicable

Pediatric and Adolescent Patellar Instability

240 participantsStarted 2015-12

Plain-language summary

This is a multi-center, randomized controlled clinical trial, the purpose of which is to determine if patients age 25 and younger who undergo medial patellofemoral ligament (MPFL) reconstruction have lower rates of recurrent instability compared to those treated non-operatively. The MPFL is a ligament that stabilizes the kneecap, and maintains its proper position in the groove on the femur (thighbone). Instability refers to a situation in which the kneecap moves out of place, or dislocates. When instability is recurrent, it occurs more than once in the same knee.

Who can participate

Age range8 Years – 25 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients must be age 25 or younger * Patients must be first-time dislocators, meaning have had only one episode of patellar instability, during which they dislocated their patella (kneecap) Exclusion Criteria: * Patients with more than one episode of patellofemoral instability * Patients who have had prior patellofemoral surgery on the knee of interest * Patients with large cartilage tears in the knee. These patients will undergo stabilization of the patellofemoral joint (MPFL reconstruction) as per standard of care, and will not be included in the study.

What they're measuring

Recurrence of patellar instability

Timeframe: 5 years

Trial details

NCT IDNCT02333825

SponsorHospital for Special Surgery, New York

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12

View on ClinicalTrials.gov More Patellar Instability trials